FEATURED/ARCHIVES (28/04/24)
Movement Side Effects of Antipsychotic Drugs in Adults with and without Intellectual Disability: UK Population-Based Cohort Study · August 2017
Articles
BMJ Open
Efficacy and Safety of Auricular Acupuncture for Cognitive Impairment and Dementia: A Systematic Review · May 2018
Articles
Evidence-Based Complementary and Alternative Medicine
Genetic and Environmental Correlates of Topiramate-Induced Cognitive Impairment · November 2011
Articles (Manuscripts-Versions)
PubMed Central>Epilepsia
Depression, Anxiety and Adjustment Disorder among Patients with Psoriasis Receiving Systemic Agents: A Retrospective Cohort Study in Quebec, Canada · August 2022
Articles
JEADV Clinical Practice
Seizure and Delirium Secondary to Carboplatin and Pantoprazole Therapy-Induced Hypomagnesemia in a Cancer Patient · August 2021
Articles
Clinical Case Reports
Catatonic Symptoms Appearing Before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia · October 2016
Articles
Internal Medicine
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms with Intramuscular Antipsychotics for the Treatment of Agitation · December 2008
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Psychiatry
Effectiveness and Safety of Intravenous Valproate in Agitation: A Systematic Review · November 2021
Abstracts
Psychopharmacology
Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial · May 2017
Articles
Evidence-Based Complementary and Alternative Medicine
The Efficacy and Safety of Anti-AB Agents for Delaying Cognitive Decline in Alzheimer’s Disease: A Meta-Analysis · November 2023
Articles
Frontiers in Aging Neuroscience
Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program · March 2021
Abstracts
CNS Drugs
A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia · January 2013
Articles
Psychiatry and Clinical Psychopharmacology
Quetiapine-Induced Acute-Onset Catatonia · May 2023
Articles
Primary Care Companion for CNS Disorders
Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing · December 2021
Articles
International Journal of Environmental Research and Public Health
A Case Report of Catatonia and Neuroleptic Malignant Syndrome with Multiple Treatment Modalities: Short Communication and Literature Review · October 2015
Articles
Medicine
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia · May 2021
Articles
American Journal of Psychiatry
Feasibility, Efficacy, and Safety of Antipsychotics for ICU Delirium: the MIND Randomized, Placebo-Controlled Trial · February 2010
Articles (Manuscripts-Versions)
PubMed Central>Critical Care Medicine
Ketamine for Pharmacological Management of Aggression and Agitation in Pre-Hospital Settings: A Review of Comparative Clinical Effectiveness, Safety and Guidelines · May 2019
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Do the Dissociative Side Effects of Ketamine Mediate Its Antidepressant Effects? · February 2014
Articles (Manuscripts-Versions)
PubMed Central>Journal of Affective Disorders
Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study · January 2007
Articles (Manuscripts-Versions)
PubMed Central>Journal of Child and Adolescent Psychopharmacology